Skip to main content
Caplight Logo









Mosaic Therapeutics

Mosaic Therapeutics

Private
CambridgeHealthcare & Life Scienceshttps://mosaic-tx.com/

Last Round

Strategic

Apr 24, 2025

Total Funding Raised

$28M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mosaic Therapeutics is a biotechnology company that develops targeted oncology therapies for patient groups with unmet medical needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

precision oncologydrug discoverycomputational biologyai drug discoverybiotechsmall molecule inhibitorspatient stratificationgenetic vulnerabilitiestherapeutic targetsin silico drug discoverybiomarker discoverycancer researchdrug developmenttechbiogenomic data

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mosaic Therapeutics Comparables

Compare Mosaic Therapeutics with similar companies based on industry and business-model similarity.

Mosaic Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enedra Therapeutics
88%
Evariste
83%
Eisbach Bio GmbH
83%

Mosaic Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 24, 2025
Series AApr 4, 2023

Key People

Founding team and executive leadership

Magdalena Jonikas

Board Director, Interim Chief Executive Officer

Executive Team

Mosaic Therapeutics Investors

Notable investors and investment history

Mosaic Therapeutics investors
InvestorRounds
Cambridge Innovation CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 96% MoM, reaching 1.5K.

  • Jan 1, 2026

    Preclinical data for lead program MOS101 disclosed at AACR Annual Meeting 2026.

Mosaic Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mosaic Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mosaic Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range20
Year Founded2020
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?